Product Name |
CAS No. |
Usage |
(2-n-Butyl-5-chloro-imidazole-4-yl)-carboxaldehyde (BCFI) |
83857-96-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
(S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinoline carboxylic acid benzyl ester p-toluenesulfonate salt |
82586-59-2 |
Intermediate of Moexipril HCL [1033775-10-6] |
(s,s)-2-azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride |
93779-29-4 |
Intermediates of Ramipril [87333-19-5] |
(s,s,s)-2-azabicyclo[3,3,0]-octane-3-carboxylic acid benzylester hydrochloride |
93779-31-8 |
Intermediate of Ramipril [87333-19-5] |
[5-(1-Hydroxyl-1-methylethyl)-2-propyl-imidazol-4-yl] carboxylic acid ethyl ester |
144689-93-0 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
1-(1,4-Benzodioxane-2-carbonyl)piperazine |
70918-00-2 |
Intermediate of Doxazosin Mesylate [77883-43-3] |
1-chloroethyl chlorofomate |
50893-53-3 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
1-chloroethyl cyclohexyl carbonate |
99464-83-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
2-(2-Methoxy phenoxy)-ethylamine hydrochloride |
64464-07-9 |
Intermediate of Carvedilol [72956-09-3] |
2-Cyano-4'-bromomethylbiphenyl |
114772-54-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
2-Cyano-4'-Methyl Biphenyl |
114772-53-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
2-N-butyl-4-spiro-cyclopentane-2-imidazoline 5 one HCl |
151257-01-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
2-n-Propyl-4-methyl-6-(1'-methylbenzimidazol-2'-yl)benzimidazole |
152628-02-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
4-(2, 3-Epoxypropoxy)-carbazole |
51997-51-4 |
Intermediate of Carvedilol [72956-09-3] |
4-Bromomethyl-2'-(2-trityl-2H-tetrazol-5-yl)biphenyl (TTBB) |
124750-51-2 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
5-(4'-Bromomethyl-biphenyl-2-yl)-2-trityl-2H-tetrazole |
|
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
butyl (3s)3-amino-2,3,4,5-tetrahydro-1h-[1]benzazepin-2-one-1-acetate |
109010-30-8 |
Intermediate of Benazepril [86541-74-4] |
ECPPA / n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine |
82717-96-2 |
Intermediate of Enalapril Maleate [76095-16-4] |
ECPPA Na / n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl carboxy anhydride |
84793-24-8 |
Intermediate of Enalapril Maleate [76095-16-4] |
Ethyl [2-ethoxy-1-[(2กฏ-cyanobiphenyl-4-yl)methyl]benzimidazol-7-yl] carboxylate |
139481-41-7 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/ Eprosartan[133040-01-4]/ Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate |
136285-67-1 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
Methyl 2-acetylamino-3-chloropropionate |
18635-38-6 |
Intermediate of Ramipril [87333-19-5] |
Methyl 4'-bromomethyl biphenyl-2-carboxylate |
114772-38-2 |
Intermediate of Telmisartan [144701-48-4] |
N-[(2'-cyano(1.1'-biphenyl)-4-yl)methyl]methylester]-l-valine hydrochloride |
137863-89-9 |
Intermediate of Sartan group drugs (Losartan[114798-26-4]/Valsartan[137862-53-4]/Irbesartan[138402-11-6]/Eprosartan[133040-01-4]/Candesartan[139481-59-7]/Olmesartan[144689-24-7]) |
n-6-trifluoro acetyl-l-lysine |
10009-20-8 |
Intermediate of Lisinopril Dihydrate [83915-83-7] |
N-acethyl-3-chloro-l-serine methyl ester |
87333-22-0 |
Intermediates of Ramipril [87333-19-5] |
N-Methyl-1,2-benzenediamine dihydrochloride |
25148-68-9 |
Intermediate of Telmisartan [144701-48-4] |
Trans-4-cyclohexyl-l-proline |
103201-78-1 |
Intermediate of Fosinopril [98048-97-6] |
Trityl irbesartan |
138402-10-5 |
Intermediate Irbesartan[138402-11-6] |
Trityl losartan |
133909-99-6 |
Intermediate of Losartan[114798-26-4] |
Trityl valsartan |
195435-23-5 |
Intermediate of Valsartan[137862-53-4] |